Pharmaceutical Industry Reports
Phenylketonuria Treatment

Published on 16 July 2018 in “Health & Fitness”, language — English. 8 pages.

Publication description:

KUVAN (sapropterin dihydrochloride) is a U.S. Food and Drug Administration approved drug which is majorly used in the treatment of Phenylketonuria. More

Show Tags

Tags: phenylketonuria treatment market growth

Read

Other publications of “Pharmaceutical Industry Reports”

View all publications

Pharmaceutical Industry Reports Phenylketonuria Treatment

Other publications of “Pharmaceutical Industry Reports”

Related Magazines

Pharmaceutical Industry Reports
Phenylketonuria Treatment